152 related articles for article (PubMed ID: 6457624)
21. Preservation of platelets and their function in prolonged cardiopulmonary bypass using prostacyclin.
Koshal A; Krausz MM; Utsunomiya T; Hechtman HB; Collins JJ; Cohn LH
Circulation; 1981 Aug; 64(2 Pt 2):II44-8. PubMed ID: 7018736
[TBL] [Abstract][Full Text] [Related]
22. Systemic and transcardiac platelet activity in acute myocardial infarction in man: resistance to prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Circulation; 1985 Dec; 72(6):1336-45. PubMed ID: 2933181
[TBL] [Abstract][Full Text] [Related]
23. The effect of prostacyclin infusion on platelet hemostatic function in patients undergoing cardiopulmonary bypass.
Malpass TW; Amory DW; Harker LA; Ivey TD; Williams DB
J Thorac Cardiovasc Surg; 1984 Apr; 87(4):550-5. PubMed ID: 6231433
[TBL] [Abstract][Full Text] [Related]
24. Effect of nafazatrom on platelet function and release: relationship to symptomatic episodes in patients with peripheral vascular disease.
Buchanan MR; Butt RW; Turpie AG
Am Heart J; 1987 May; 113(5):1133-7. PubMed ID: 2953219
[TBL] [Abstract][Full Text] [Related]
25. [Antiaggregant effect and tolerance of calcium carbasalate administrated immediately after aorto-coronary bypass. Results of a double-blind versus placebo study].
Mathieu P; Villemot JP; Stoltz JF; Scheck F; Garnier LF
Pathol Biol (Paris); 1996 Jun; 44(6):571-80. PubMed ID: 8977914
[TBL] [Abstract][Full Text] [Related]
26. Prostacyclin in aortocoronary bypass surgery: a double-blind, placebo-controlled study.
Heinrich D; Schleussner E; Wagner WL; Sellmann-Richter R; Hehrlein FW
Thromb Res; 1983 Nov; 32(4):409-26. PubMed ID: 6362060
[TBL] [Abstract][Full Text] [Related]
27. Effects of prostacyclin during cardiopulmonary bypass in man.
Rådegran K; Egberg N; Papaconstantinou C
Scand J Thorac Cardiovasc Surg; 1981; 15(3):263-8. PubMed ID: 6753137
[No Abstract] [Full Text] [Related]
28. A prospective, randomized study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations.
Fish KJ; Sarnquist FH; van Steennis C; Mitchell RS; Hilberman M; Jamieson SW; Linet OI; Miller DC
J Thorac Cardiovasc Surg; 1986 Mar; 91(3):436-42. PubMed ID: 3512919
[TBL] [Abstract][Full Text] [Related]
29. A comparative study of prostacyclin infusion given before and during cardiopulmonary bypass to assess the first pass effect of the circuit on platelet number and function.
Jestice HK; Humphreys JE; English TA; Hoggarth CE; Wells FC
Eur J Cardiothorac Surg; 1990; 4(1):40-4. PubMed ID: 2106334
[TBL] [Abstract][Full Text] [Related]
30. Blood platelets in cardiopulmonary bypass operations. Recovery occurs after initial stimulation, rather than continual activation.
Zilla P; Fasol R; Groscurth P; Klepetko W; Reichenspurner H; Wolner E
J Thorac Cardiovasc Surg; 1989 Mar; 97(3):379-88. PubMed ID: 2918735
[TBL] [Abstract][Full Text] [Related]
31. [Effects of prostacyclin (PGI2) on tachycardic heart arrhythmias following aortocoronary venous bypass operations].
Heinrich D; Wagner WL; Höge R
Herz; 1985 Dec; 10(6):357-65. PubMed ID: 3936760
[TBL] [Abstract][Full Text] [Related]
32. Increased prostacyclin and thromboxane production in man during cardiopulmonary bypass.
Ylikorkala O; Saarela E; Viinikka L
J Thorac Cardiovasc Surg; 1981 Aug; 82(2):245-7. PubMed ID: 7019583
[TBL] [Abstract][Full Text] [Related]
33. Assessment of platelet function in patients with Raynaud's syndrome.
Hutton RA; Mikhailidis DP; Bernstein RM; Jeremy JY; Hughes GR; Dandona P
J Clin Pathol; 1984 Feb; 37(2):182-7. PubMed ID: 6229551
[TBL] [Abstract][Full Text] [Related]
34. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
[No Abstract] [Full Text] [Related]
35. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease.
Zahavi J; Zahavi M
Thromb Haemost; 1985 Feb; 53(1):105-9. PubMed ID: 3158092
[TBL] [Abstract][Full Text] [Related]
36. Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndrome.
Wilson AP; Efthimiou J; Betteridge DJ
Eur J Clin Invest; 1988 Aug; 18(4):410-4. PubMed ID: 2971547
[TBL] [Abstract][Full Text] [Related]
37. Platelet half-life in comparison to other in-vivo platelet function parameters such as thromboxane B2, beta-thromboglobulin and platelet factor 4 in patients with atherosclerotic lesions with and without hyperlipoproteinemia.
Strobl-Jäger E; Fitscha P; Kaliman J; Widhalm K; Sinzinger H
Vasa; 1986; 15(4):373-8. PubMed ID: 2948337
[No Abstract] [Full Text] [Related]
38. Prostacyclin infusion during extracorporeal circulation foe coronary bypass.
Rådegran K; Arén C; Teger-Nilsson AC
J Thorac Cardiovasc Surg; 1982 Feb; 83(2):205-11. PubMed ID: 7035754
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of platelet function by ticlopidine in arteriosclerosis obliterans of the lower limbs.
Davì G; Pinto A; Francavilla G; Paterna S; Campisi D; Strano A
Thromb Res; 1985 Oct; 40(2):275-81. PubMed ID: 2933846
[No Abstract] [Full Text] [Related]
40. Effects of bopindolol on platelet function in hypertension at rest and during exercise.
Virgolini I; Fitscha P; Rauscha F; Sinzinger H
Prostaglandins Leukot Essent Fatty Acids; 1990 Jun; 40(2):125-30. PubMed ID: 2143586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
